Balyasny Asset Management »

Black Diamond Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 511k 2.13
2024-03-31 $177k 35k 5.07
2021-03-31 $690k 28k 24.25

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
NEA Management Company
Acadian Asset Management
Vanguard Group
Dimensional Fund Advisors
Marshall Wace
BlackRock
Connor, Clark & Lunn Investment Management
Siren
Arrowstreet Capital, Limited Partnership
Renaissance Technologies
Mackenzie Financial
Goldman Sachs Group
Citadel Advisors
UBS Group

View all funds holding Black Diamond Therapeutics